Results 191 to 200 of about 3,418,065 (230)
Some of the next articles are maybe not open access.
The Extent of Surgery for Thyroid Medullary Cancer
Tumori Journal, 1994Aims Evaluation of the impact of the extent of primary surgery and reintervention on the outcome of patients with medullary thyroid carcinoma. Methods Seventy-two patients with medullary thyroid carcinoma (MTC) were surgically treated ...
Pelizzo M. R. +8 more
openaire +4 more sources
Endocrine Abstracts, 2015
Medullary thyroid cancer (MTC) is an uncommon disease, accounting for 3–10 % of all thyroid cancers worldwide [1–3]. The German literature contains reports of a thyroid malignancy with amyloid deposits as early as 1906, but it was not until 1959 when Hazard and co-workers reported on a clinicopathological, solid arrangement of cells, which represented ...
Laura Chin-Lenn, Janice L. Pasieka
+4 more sources
Medullary thyroid cancer (MTC) is an uncommon disease, accounting for 3–10 % of all thyroid cancers worldwide [1–3]. The German literature contains reports of a thyroid malignancy with amyloid deposits as early as 1906, but it was not until 1959 when Hazard and co-workers reported on a clinicopathological, solid arrangement of cells, which represented ...
Laura Chin-Lenn, Janice L. Pasieka
+4 more sources
Surgical Clinics of North America, 1995
Medullary thyroid cancer is a tumor of the thyroid C cells that occurs in sporadic and hereditary clinical settings. Genetic testing of at-risk individuals is available and has been applied to patient management. Plasma calcitonin levels are a very sensitive marker for the presence of disease.
openaire +2 more sources
Medullary thyroid cancer is a tumor of the thyroid C cells that occurs in sporadic and hereditary clinical settings. Genetic testing of at-risk individuals is available and has been applied to patient management. Plasma calcitonin levels are a very sensitive marker for the presence of disease.
openaire +2 more sources
2021
MTC is a rare thyroid malignancy that is associated with a worse prognosis than follicular-derived thyroid cancers. It can occur sporadically or as part of hereditary syndromes such as MEN2 with various clinical phenotypes dependent on the tumor genotype. The mainstays for treatment are early diagnosis and surgical removal of all disease.
Victor A. Gall, Amanda M. Laird
openaire +2 more sources
MTC is a rare thyroid malignancy that is associated with a worse prognosis than follicular-derived thyroid cancers. It can occur sporadically or as part of hereditary syndromes such as MEN2 with various clinical phenotypes dependent on the tumor genotype. The mainstays for treatment are early diagnosis and surgical removal of all disease.
Victor A. Gall, Amanda M. Laird
openaire +2 more sources
Sporadic Medullary Thyroid Cancer
2009Medullary thyroid cancer (MTC), is a tumor of the parafollicular / c-cells of the thyroid gland. These cells are derived from the embryonic neural crests and make up 1% of the thyroid cells. C-cells can be found anywhere in the gland but are concentrated in the upper poles of the thyroid lobes.
Adrian, Harvey, Janice L, Pasieka
openaire +2 more sources
DeckerMed CGSO Case-Based Reviews, 2018
Medullary thyroid cancer (MTC) arises from the thyroid C-cells and accounts for 1 to 2% of thyroid cancers in the United States. Most tumors are sporadic but may occur as a part of the familial syndromes multiple endocrine neoplasia (MEN) 2A, MEN2B, and familial MTC.
Ganapathi Bantwal, Vivek Mathew
openaire +2 more sources
Medullary thyroid cancer (MTC) arises from the thyroid C-cells and accounts for 1 to 2% of thyroid cancers in the United States. Most tumors are sporadic but may occur as a part of the familial syndromes multiple endocrine neoplasia (MEN) 2A, MEN2B, and familial MTC.
Ganapathi Bantwal, Vivek Mathew
openaire +2 more sources
[Medullary cancer of the thyroid].
Soins; la revue de reference infirmiere, 1991Medullary thyroid cancer (MTC) is either of the sporadic or familial type, whether it be isolated or constitute part of a type II multiple endocrine neoplasia. Progress in the knowledge of the disease has recently been obtained in the following ways: the IRMA assay of mature calcitonin, the disease marker, has permitted earlier diagnosis of familial ...
C, Guillausseau-Scholer +1 more
openaire +3 more sources
2019
Medullary thyroid cancer is very rare since it represents about 0.2% of all human tumors. It can be sporadic (75%) or familial (25%), and in both cases the pathogenesis is related to the presence of activating mutations of RET oncogene at somatic or germline level, respectively.
Rossella Elisei, Cristina Romei
openaire +1 more source
Medullary thyroid cancer is very rare since it represents about 0.2% of all human tumors. It can be sporadic (75%) or familial (25%), and in both cases the pathogenesis is related to the presence of activating mutations of RET oncogene at somatic or germline level, respectively.
Rossella Elisei, Cristina Romei
openaire +1 more source
2017
Sažeti prikaz nastanka, kliničke slike, dijagnosticiranja i liječenja medularnog karcinoma štitne žlijezde.
Kusić, Zvonko +7 more
openaire +1 more source
Sažeti prikaz nastanka, kliničke slike, dijagnosticiranja i liječenja medularnog karcinoma štitne žlijezde.
Kusić, Zvonko +7 more
openaire +1 more source
[Medullary cancer of the thyroid].
La Revue du praticien, 1997Although rare (10% of thyroid cancers), medullary thyroid cancer is remarkable by the presence of a specific biological marker; elevation of blood calcitonin. It allows its preoperative diagnosis and this extensive surgery which is the only efficient treatment.
openaire +2 more sources